TLPH (Talphera) Days Payable: 0.00 (As of Mar. 2026)


TLPH Talphera Inc TLPH
34 GF Score
Price $1.03
! 3 Warning Signs
View Full Analysis

What is Talphera Days Payable?

Talphera TLPH -3.76% 34 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates TLPH with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Talphera ranks worse than 108342.25% on this metric.

Talphera's average Accounts Payable for the three months ended in Mar. 2026 was $0.74 Mil. Talphera's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Talphera's Days Payable or its related term are showing as below:

During the past 13 years, Talphera's highest Days Payable was 751.59. The lowest was 46.22. And the median was 134.85.

TLPH's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.98
* Ranked among companies with meaningful Days Payable only.

Talphera's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same


Talphera Days Payable Historical Data

* Premium members only.

The historical data trend for Talphera's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talphera Days Payable Chart

Talphera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 236.23 751.59 0.00 0.00 0.00

Talphera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TLPH vs INIS, IXHL, ZYBT: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Talphera's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talphera Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Talphera's Days Payable distribution charts can be found below:

* The bar in red indicates where Talphera's Days Payable falls into.


TLPH
34GF Score
Talphera Inc TLPH
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talphera Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Talphera's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.67 + 0.544) / 2 ) / 0*365
=0.607 / 0*365
=N/A

Talphera's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.544 + 0.927) / 2 ) / 0*365 / 4
=0.7355 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Talphera (TLPH) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Talphera and its competitors. Over the past decade, Talphera's Days Payable has ranged from 46.22 to 751.59. According to the industry distribution chart, Talphera ranks #999999 out of 923 companies in the Drug Manufacturers industry.
Is Talphera's Days Payable too high?
Talphera's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 46.22 to a high of 751.59. Based on the distribution chart, Talphera ranks #999999 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Talphera has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Talphera's Days Payable compare to INIS and IXHL?
According to the Drug Manufacturers industry distribution chart, Talphera ranks #999999 out of 923 companies for Days Payable. This places Talphera in the lower half of its industry. The industry median Days Payable is 90.98. Historically, Talphera's own Days Payable has ranged from 46.22 to 751.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Talphera and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Talphera's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talphera stock overvalued right now?
Talphera (TLPH) has a current Days Payable of 0.00. The current Days Payable is 0.00. Talphera's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Talphera (TLPH), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talphera Business Description

Other Exchanges R5XA:Germany
Address 1850 Gateway Drive, Suite 175, San Mateo, CA, USA, 94404
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
34GF Score

Get the complete analysis for TLPH

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.03
Price